Comparison

TAK-901 European Partner

Item no. TMO-T2709-25mg
Manufacturer TargetMol
CASRN 934541-31-8
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL x 10 mM (in DMSO) 1 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias TAK901
Similar products 934541-31-8
Shipping Condition Cool pack
Available
Manufacturer - Targets
Src|||JAK|||Aurora Kinase|||CDK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
504.64
Description
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
Pathways
JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Cell Cycle/Checkpoint|||Angiogenesis|||Stem Cells

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close